SCHEMBL20524901

SCHEMBL20524901

Clc1ccc2[nH]c3c(c2c1)CCNc1ccccc1-3

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 5/20 0.62
CDK5R1 Q15078 5/20 0.62
GSK3B P49841 5/20 0.62
CCNB2 O95067 4/20 0.62
CDK1 P06493 4/20 0.62
CCNB1 P14635 4/20 0.62
CCNB3 Q8WWL7 4/20 0.62
KDM4E B2RXH2 3/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 1/20 0.50
HTR2A P28223 9/20 0.48
HTR2C P28335 7/20 0.48
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
USP2 O75604 1/20 0.46
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29908708 0.84 MEN1 (0.61) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL272876 0.84 MEN1 (0.61) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL4552964 0.84 CDK1 (0.62) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL20524909 0.82 GSK3B (0.65) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL6350624 0.77 KDM4E (0.69) CDK5GSK3BKDM4ELMNAGAA
SCHEMBL5688188 0.76 GSK3B (1.00) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL20807162 0.71 CCNB2 (0.53) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL1985243 0.71 MEN1 (0.71) CDK5CDK5R1GSK3BCCNB2CDK1
SCHEMBL21724805 0.69 PRKD1 (0.71) CDK5GSK3BKDM4ELMNAGAA
SCHEMBL2824450 0.68 KDM4E (0.61) CDK5CDK5R1GSK3BCCNB2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3600259-A1 NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING INDIRUBIN AND DERIVATIVES THEREOF AND METHODS OF MAKING AND USING THE SAME Phosphorex, Inc. (US) 2020-02-05 EP disclosed
WO-2018183631-A1 NOVEL PHARMACEUTICAL FORMULATIONS CONTAINING INDIRUBIN AND DERIVATIVES THEREOF AND METHODS OF MAKING AND USING THE SAME PHOSPHOREX, INC. (US) 2018-10-04 WO disclosed